Hypoxia‐related altitude illnesses

N Netzer, K Strohl, M Faulhaber… - Journal of travel …, 2013 - academic.oup.com
Background Millions of tourists and climbers visit high altitudes annually. Many
unsuspecting and otherwise healthy individuals may get sick when sojourning to these high …

Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis

EV Low, AJ Avery, V Gupta, A Schedlbauer… - bmj, 2012 - bmj.com
Objectives To assess the efficacy of three different daily doses of acetazolamide in the
prevention of acute mountain sickness and to determine the lowest effective dose. Design …

Interventions for preventing high altitude illness: Part 1. Commonly‐used classes of drugs

VHN Estrada, DM Franco, RD Medina… - Cochrane Database …, 2017 - cochranelibrary.com
Background High altitude illness (HAI) is a term used to describe a group of cerebral and
pulmonary syndromes that can occur during travel to elevations above 2500 metres (8200 …

Interventions for treating acute high altitude illness

D Simancas‐Racines… - Cochrane Database …, 2018 - cochranelibrary.com
Background Acute high altitude illness is defined as a group of cerebral and pulmonary
syndromes that can occur during travel to high altitudes. It is more common above 2500 …

Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis

B Kayser, L Dumont, C Lysakowski… - … altitude medicine & …, 2012 - liebertpub.com
Abstract Kayser, Bengt, Lionel Dumont, Christopher Lysakowski, Christophe Combescure,
Guy Haller, Martin R. Tramèr. Reappraisal of acetazolamide for the prevention of acute …

Acetazolamide for the prevention of acute mountain sickness—a systematic review and meta‐analysis

ND Ritchie, AV Baggott… - Journal of travel …, 2012 - academic.oup.com
Background Acetazolamide has been reported to be effective in the prevention of acute
mountain sickness (AMS). Our aim was to conduct a systematic review of randomized …

Nrf2 activation: a potential strategy for the prevention of acute mountain sickness

C Lisk, J McCord, S Bose, T Sullivan, Z Loomis… - Free Radical Biology …, 2013 - Elsevier
Reactive oxygen species (ROS) formed during acute high altitude exposure contribute to
cerebral vascular leak and development of acute mountain sickness (AMS). Nuclear factor …

Advances in the available non-biological pharmacotherapy prevention and treatment of acute mountain sickness and high altitude cerebral and pulmonary oedema

KE Joyce, SJE Lucas, CHE Imray… - Expert Opinion on …, 2018 - Taylor & Francis
Introduction: The physiological responses on exposure to high altitude are relatively well
known, but new discoveries are still being made, and novel prevention and treatment …

Reduced acetazolamide dosing in countering altitude illness: a comparison of 62.5 vs 125 mg (the RADICAL Trial)

SE McIntosh, M Hemphill, MC McDevitt… - Wilderness & …, 2019 - journals.sagepub.com
Introduction North American guidelines propose 125 mg acetazolamide twice daily as the
recommended prophylactic dose to prevent acute mountain sickness (AMS). To our …

Effects of the 8 psia/32% O2 Atmosphere on the Human in the Spaceflight Environment

J Norcross, P Norsk, J Law, D Arias, J Conkin… - 2013 - ntrs.nasa.gov
Extravehicular activity (EVA) is at the core of a manned space exploration program. There
are elements of exploration that may be safely and effectively performed by robots, but there …